Vibrant Pharmachem Pvt Ltd has moved the Ministry of Environment and Forests for environmental clearance to its unit for manufacturing bulk drugs at Raichur in Karnataka.

In its presentation to the Ministry for environmental clearance, the company said that it intends to produce 8.4 MT of bulk drugs and intermediates.

The unit proposes to produce Amlodipine Besylate, Aripiprazole, Atrovastain Calcium, Carvedilio, Clopidogrel Bisulphate, Gemcitabine Hydrochloride, Itraconazole, Lamotrigine, Montelokast Sodium, Olmesertan, Pantoprazole Sodium, Quitiapine Fumarate, Terbinafine Hydrochloride and Tramadol.

The total plot area of the unit is 8098.73 sq m, of which 3071.65 sq m is for greenbelt development. The total investment in the project is Rs 298.61.

Fugitive emissions in production blocks will be avoided by consuming solvents immediately. Process emissions are mitigated by effective scrubbing. Fugitive emissions from storage tanks will be avoided by providing air condensers, the company said.

There will be plants in the open area and outside the unit?s premises along the road. The company said the project site is totally private agricultural land and there is no forest land or water body within the project site. Also there is no reserved forest within the area.

There are also no historical places, defence installations, archaeological sites, wildlife sanctuaries or national parks and ecologically-sensitive areas near the project site.

In its presentation, the company said there will not be any major potential for negative impact on the environment due to the proposed project. On the contrary, there will be positive impact on the socio-economic environment since the project will generate some permanent and secondary employment and it will increase direct and indirect employment opportunities, the company said.

The company said it will adopt all safety and hazard identification measures besides a strong disaster management policy.